Exploring Affinity Capture in AAV Platform Downstream ProcessingExploring Affinity Capture in AAV Platform Downstream Processing

This webcast features: Nicolas Laroudie, Staff Scientist, Field Applications, Thermo Fisher Scientific.

Recent years have witnessed a rapid increase in early phase clinical trials and successful regulatory approvals for multiple AAV-based therapies utilizing diverse serotypes. Amidst the pursuit of delivering novel, high quality, and safe AAV products, the importance of an efficient, scalable, and platformable purification process for a variety of AAV serotypes is paramount for both pharmaceutical developers and contract development and manufacturing organizations (CDMOs).

This webinar investigates the critical considerations when assessing an affinity capture step within a comprehensive AAV vector purification strategy. Parameters such as specificity, binding capacity, purity, yield, scalability, and reusability will be thoroughly examined. We will also share performance data of the industry-leading Thermo Scientific^TM POROS^TM CaptureSelect^TM AAV affinity resin in relation to other commercially available options.

Key Takeaways:

Just fill out the form below to watch the recorded webcast now.